R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher is of the view that Jubilant Life Sciences can give handsome returns.
first published: Dec 10, 2015 04:33 pm
A collection of the most-viewed Moneycontrol videos.

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live

Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live

Redefining Distribution with Next-Gen Technology Solutions
You are already a Moneycontrol Pro user.

